 | Spero Therapeutics, Inc. | |||
| NMS : SPRO || Location: United States | ||||
$1.4-0.07 (-4.76%) |
0.38 M | 1.4 - 1.54 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.654 M |
| March 15, 2024 | 0.614 M |
| Feb. 29, 2024 | 0.564 M |
| Feb. 15, 2024 | 0.619 M |
| Jan. 31, 2024 | 0.707 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.10 | 0.96 | 1041.18% |
| 09/30/2023 | -0.03 | 0.04 | 230.72% |
| 06/30/2023 | -0.35 | -0.23 | 34.32% |
| 03/31/2023 | -0.34 | -0.25 | 26.47% |
| 12/31/2022 | 0.04 | 0.55 | 1144.34% |
SPRO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 53.869M | Shares Float | 37.429M |
| Short Float | 0.654M | Market Cap | 79.19M |
| Institution ownership | 26.12% | Insider ownership | 20.376% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.41 | Forward EPS | -0.95 |